NCT03956459View on ClinicalTrials.gov

Evaluation of PET-CT Scanner Performances to Detect Infra-centimetric Lesions in Patients With Cancer

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 25, 2019

Primary Completion Date

February 4, 2021

Study Completion Date

February 4, 2021

Conditions
Cancer
Interventions
OTHER

Patients with a cancer for which a FDG-PET scanner must be performed

"For each patient, 2 consecutive PET-CT scanners will be performed using 2 different systems of PET-CT scanners:~* Discovery MI~* Discovery IQ~Only one contrast agent injection (FDG) will be given for both scanners."

Trial Locations (1)

Unknown

Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse

All Listed Sponsors
lead

Institut Claudius Regaud

OTHER

NCT03956459 - Evaluation of PET-CT Scanner Performances to Detect Infra-centimetric Lesions in Patients With Cancer | Biotech Hunter | Biotech Hunter